Effect of oral glucose on acylated and total Ghrelin secretion in acromegalic patients

Neuroendocrinology Letters

Volumn 28, Issue 5, 2007, Pages 596-603

  Isidro, Maria Luisa ^a   Nemiña, Rosa ^a,b   Garcia Buela, Jesús ^a   Sangiao Alvarellos, Susana ^a,b   Cordido, Fernando ^a,b  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Acromegaly; Acylated ghrelin; Oral glucose

Indexed keywords

GHRELIN; GLUCOSE; INSULIN;

ACROMEGALY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; PATHOPHYSIOLOGY; PROTEIN SECRETION;

EID: 38049018468     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Adeghate E and Ponery AS (2002). Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol. 14: 555-560.
2. Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, et al. (2004). Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 150: 447-455.
3. Alvarez P, Isidro L, Garcia-Buela J, Leal-Cerro J, Broglio F, Tassone F, et al. (2004). Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol. 61: 250-255.
4. Alvarez-Castro P, Isidro ML, Garcia-Buela J, Dieguez C, Casanueva FF, Cordido F. (2006). Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients. Diabetes Obes Metab. 8: 555-560.
5. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, et al. (2001). Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 86: 4753-4758.
6. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M. (2003). Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut. 52: 947-952.
7. Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA. (2003). Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab. 88: 2180-2184.
8. Bolanowski M, Zatonska K, Kaluzny M, Zielinski G, Bednarek-Tupikowska G, Bohdanowicz-Pawlak A et al. (2006). A follow-up of 130 patients with acromegaly in a single centre. Neuro Endocrinol Lett. 27: 828-832.
9. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. (2001). Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 86: 5083-6.
10. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S, Gauna C. (2003a).The endocrine response to ghrelin as a function of gender in human young and elderly subjects. J Clin Endocrinol Metab. 88: 1537-1542.
11. Broglio F, Gottero C, Benso A, Prodam F, Destefanis S, Gauna C, et al. (2003b). Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab. 88: 4268-4272.
12. Caixas A, Bashore C, Nash W, Pi-Sunyer X, and Laferrere B. (2002). Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Enclocrinol Meta b. 87: 1902-1905.
13. Cappiello V, Ronchi C, Mospurgo PS, Epaminonda P, Beck-Peccoz P, Spada A. (2002). Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol. 147: 189-194.
14. Cordido F, Peñalva A, Dieguez C and Casanueva F. (1993). Massive growth hormone (GH) discharge in obese subjects after the combined administration of Growth Hormone releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab. 76: 819-823.
15. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. (2002). Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 346: 1623-1630.
16. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, et al. (2002). Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 8: 643-644.
17. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 50: 1714-1719.
18. Dall R, Kanaley J, Hanse TK, Moller N, Christiansen JS, Hosoda H, et al. (2002). Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol. 147: 65-70.
19. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. (2002). Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 51: 124-129.
20. Eden Engström B, Burman P, Holdstock C, Karlsson FA.: (2003) Effects of GH on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab. 88: 5193-5198.
21. Egido EM, Rodriguez-Gallardo J, Silvestre RA and Marco J (2002). Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol. 146: 241-244.
22. Espelund U, Hansen TK, Hojlund K, Beck-Nielsen H, Clausen JT, Hansen BS, et al. (2005). Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: Studies in obese and normal-weight subjects. J Clin Endocrinol Metab. 90: 741-746.
23. Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw SL. (2003) Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J Clin Endocrinol Metab. 88: 2037-2044.
24. Gauna C, Meyler FM, Janssen J, Delhanty PJD, Abribat T, van Koetsveld P, et al. (2004). Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab. 89: 5035-5042.
25. Giavoli C, Cappiello V, Corbetta S, Ronchi CL, Morpugo PS, Ferrante E, et al. (2004). Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults. Clin Endocrinol. 61: 81-87.
26. Haqq AM, Farooqi IS, O'Rahilly S, Stadler DD, Rosenfeld RG, Prat KL, et al. (2003). Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab. 88: 174-178.
27. Hekimsoy Z, Ozmen B, Ulusoy (2005). Homocysteine levels in acromegaly patients. Neuro Endocrinol Lett. 26: 811-814.
28. Howard HD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. (1996). A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974-976.
29. Janssen A van der Toorn FM, Hofland LJ, van Koetsveld P, Broglio F, Ghigo E, et al. (2002). Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol. 145: 711-716.
30. Jarkovska Z, Rosicka M, Marek J, Hana V, Weiss V, Justova V, et al. (2006). Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency. Physiol Res. 55: 175-181.
31. Jung CH, Lee WY, Rhee EJ, Kim SY, Oh KW, Yun EJ, Kim SW (2006). Serum ghrelin and leptin levels in adult growth hormone deficiency syndrome. Arch Med Res. 37: 612-618.
32. Kim SW, Kim KW, Shin CS, Park DJ, Park KS, Cho BY et al. (2006). Acylated ghrelin secretion is acutely suppressed by oral glucose load or insulin-induced hypoglycaemia independently of basal growth hormone secretion in humans. Horm Res. 67: 211-219.
33. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. (1999). Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 402: 656-658.
34. Kojima M and Kangawa K (2005). Ghrelin: Structure and function. Physiol Rev. 85: 495-522.
35. Kozakowski J, Rabijewski M and Zgliczynski W (2005). Decreased in serum ghrelin levels in patients with acromegaly normalize after successful surgical treatment. Endokrynol Pol. 56: 862-870.
36. Lee HM, Wang G, Englander EW, Kojima M, Greeley Jr GH (2002). Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 143: 185-190.
37. Lucidi P, Murdolo G, Di Loreto G, De Cicco A, Parlanti N, Fanelli C et al. (2002). Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycaemia. Diabetes. 51: 2911-2914.
38. Malik IA, English PJ, Ghatei MA, Bloom SR, MacFarlane IA, Wilding JPH (2004). The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol. 60: 137-141.
39. Matthews DR, Hosker JP, Rudenski AS, Naylor DB, Treacher DF, Turner RC. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28: 412-419.
40. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. (2004). Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab. 89: 1630-1635.
41. Melmed S (2006). Acromegaly. N Engl J Med 355: 2558-73.
42. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. (2002). Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol. 440: 235-254.
43. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. (2001). A role for Ghrelin in the central regulation of feeding. Nature. 409: 194-198.
44. Nass R, Liu J, Hellmann P, Coschigano KT, Gaylinn B, Berryman DE, et al. (2004). Chronic changes in peripheral growth hormone levels do not affect ghrelin stomach mRNA expression and serum ghrelin levels in three transgenic mouse models. J Neuroendocrinol 16: 669-675.
45. Norrelund H, Hansen TK, Orskov H, Hosoda H, Kojima K, Weeke J, et al. (2002). Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol. 57: 539-546.
46. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, et al. (2001). Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 145: 669-673.
47. Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, García-Naveiro R, Isidro ML, Villaverde P, García-Buela J. (2005). Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int. 68: 2877-2885.
48. Purnell JQ, Weigle DS, Breen P, Cummings DE. (2003). Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab. 88: 5747-5752.
49. Reimer MK, Pacini G and Ahrén B (2003). Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144: 916-921.
50. Saad MF, Bernaba B, Hwu C, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R. (2002). Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab. 87: 397-400.
51. Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Woltz M, Luger A. (2003). Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes. 5: 16-20.
52. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. (2002). Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 87: 240-244.
53. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, et al. (2002). Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding and adiposity. J Clin Invest. 109: 1429-1436.
54. Tassone F, Broglio F, Destefanis S, Rovere S, Benso S, Gottero C. (2003). Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab. 88: 5478-5483.
55. Tschop M, Smiley DL and Heiman ML (2000). Ghrelin induces adiposity in rodents. Nature. 407: 908-909.
56. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. (2001) Circulating ghrelin are decreased in human obesity. Diabetes. 50: 707-709.
57. Ukkola O (2003). Ghrelin and insulin metabolism. Eur J Clin Invest. 33: 183-185.
58. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. (2004). Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endoc Rev. 25: 426-457.
59. Van der Toorn FM, Janssen JA, de Herder WW, Broglio F, Ghigo E, van der Lely AJ. (2002). Central ghrelin production does not substantially contribute to systemic ghrelin concentration: a study inn two subjects with active acromegaly. Eur J Endocrinol. 147: 195-199.
60. Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO. (2005). Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. Eur J Endocrinol. 153: 545-549.
61. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R. (2002). Expression of ghrelin and the GH secretagogue receptor by the pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab. 87: 1300-1308.
62. Wasko R, Jaskula M, Komarowska H, Zamyslowska H, Sowinski J, Waligorska-Stachura J. (2006). Ghrelin concentrations in acromegalic patients in relation to the administered therapy. Neuro Endocrinol Lett. 27: 162-168.
63. Wierup N, Svensson H, Mulder H, Sundler F (2002). The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Reg Pept. 107: 63-69
64. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG. (2001). Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 86: 5992-5998.